# Internal Development Readiness Report — The High-Agency AI Worker

## Verdict
**PASS** — the project is ready for the current internal editorial-development lane.

## Verification target
Confirm that the project is ready for internal editorial development and that external commercialization is clearly deferred.

## Check results
### 1. Artifact existence
Pass.
Verified these files exist:
- `.omx/plans/prd-internal-book-development-packet.md`
- `.omx/plans/harness-internal-book-development-packet.md`
- `.omx/plans/test-spec-internal-book-development-packet.md`
- `docs/internal-development-brief.md`
- `docs/internal-development-readiness-report.md`

### 2. Internal brief completeness
Pass.
`docs/internal-development-brief.md` now states:
- internal-use is the active lane
- external commercialization is deferred
- the canonical reading order
- locked decisions for the manuscript direction
- deferred external-only items
- recommended next internal writing moves

### 3. Reference doc alignment
Pass.
Verified alignment in:
- `README.md`
- `marketing/send-ready-packet-handoff-note.md`
- `marketing/submission-ready-publisher-packet.md`
- `marketing/send-ready-finalization-checklist.md`

All now point to the internal-development lane and treat external packaging as future-only.

### 4. Fabrication / placeholder review
Pass.
- No fabricated author identity, credential, or audience claims were added.
- Placeholder scan across new internal docs and planning docs returned **zero hits** for:
  - `[Author Name]`
  - `[insert]`
  - `TODO`
  - `TBD`
  - `FIXME`
  - `REPLACE_ME`

### 5. Project verification
Pass.
Commands run on 2026-04-15:

```bash
npm run build
npm test
```

Results:
- `npm run build` -> **Build check passed.**
- `npm test` -> **14/14 tests passed**

## Deferred external-only items
These remain intentionally deferred and are not blockers for the current lane:
- final author/byline truth data
- author bio/platform completion
- external submission packaging / merged PDF
- live editor / agent / publisher outreach

## Remaining risks
1. Existing future external-track docs still contain author placeholders by design; that is expected until commercialization resumes.
2. The repo also contains Life AB Test MVP work, so future readers should continue using `docs/internal-development-brief.md` as the book-project entry point.
